Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The 90% Effective Dose (ED90) of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscope in Adult: an up and Down Sequential Trial

NCT06333145 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06333145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06333145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The 90% Effective Dose (ED90) of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscope in Adult: an up and Down Sequential Trial
Lead sponsor
Tongji Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 4, 2024
Completion date
June 20, 2026
Enrollment
165 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug